alpha-Pinene is one of the most common monoterpenes in essential oils and appears widely across the AromaForge archive, especially in frankincense, conifer, rosemary, mastic, citrus peel, and herb profiles. Compared with many archive constituents, its literature base is broad, covering identity data, repeated occurrence, preclinical anti-inflammatory and neurobehavioral research, and some human exposure and clinical data. Even so, most direct benefit claims remain early-stage or context-specific, so archive copy should stay descriptive and non-medical.
Chemical identity and composition
PubChem lists alpha-pinene as CID 6654 with formula C10H16 and IUPAC name 2,6,6-trimethylbicyclo[3.1.1]hept-2-ene. In the local archive it is extremely widespread and can be a dominant constituent, including frankincense at 37.3%, eastern hemlock spruce at 21.44%, mastic leaf and branch at 18.12%, balsam fir at 17.10%, rosemary verbenone lots above 11%, and many smaller citrus and herb occurrences.
Aroma and practical use
- Use the recorded piney, resinous, fresh, terpenic, resin descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Compare the recorded goal signals with the intended purpose, while keeping model assumptions separate from observed study outcomes.
- Review the flagged use concerns across every contributing oil and the selected dilution.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
A 2015 study reported that alpha-pinene showed anti-inflammatory activity through suppression of MAPKs and the NF-kB pathway.
A 2015 study reported that alpha-pinene showed anti-inflammatory activity through suppression of MAPKs and the NF-kB pathway.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A daily inhalation study in mice reported significant anxiolytic-like activity across repeated exposures and measured alpha-pinene accumulation in brain and liver tissue.
A daily inhalation study in mice reported significant anxiolytic-like activity across repeated exposures and measured alpha-pinene accumulation in brain and liver tissue.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A human inhalation toxicokinetics study found about 60% relative pulmonary uptake at higher exposures and reported high blood clearance after chamber exposure to alpha-pinene.
A human inhalation toxicokinetics study found about 60% relative pulmonary uptake at higher exposures and reported high blood clearance after chamber exposure to alpha-pinene.
Apply this finding only to the studied preparation, participants, route and outcome. It does not establish the same result for a custom oil blend.
A recent randomized clinical trial tested an alpha-pinene capsule for functional dyspepsia and Helicobacter pylori management, showing that constituent-specific clinical research now exists, although it remains condition-specific and should not be generalized broadly.
A recent randomized clinical trial tested an alpha-pinene capsule for functional dyspepsia and Helicobacter pylori management, showing that constituent-specific clinical research now exists, although it remains condition-specific and should not be generalized broadly.
Apply this finding only to the studied preparation, participants, route and outcome. It does not establish the same result for a custom oil blend.
How it contributes to goal calculations
Model markers guide the formulation score. They are separate from the source findings above.
Use concerns and concentration limits
Sensitization concernFlagged
Flagged in the constituent reference; assess the source, route and finished-product concentration.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernFlagged
Flagged in the constituent reference; assess the source, route and finished-product concentration.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
No numeric constituent-specific use limit is available here. Missing is not an unrestricted-use clearance.
A national industrial chemicals assessment reports moderate acute oral toxicity in rats and recommends hazard classification based on available animal data.
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
No direct public citation is attached to this entry.
Supplier and hazard references commonly list alpha-pinene as flammable, aspiration-hazard relevant, and capable of causing allergic skin reactions after exposure.
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
No direct public citation is attached to this entry.
Because the broader pharmacology literature spans inflammation, anxiety-like behavior, gastrointestinal endpoints, and antimicrobial work, marketing copy should avoid therapeutic extrapolation from early-stage or condition-specific findings.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Constituents it may interact with
These are research candidates recorded in the interaction matrix. They do not add a proven-amplification bonus to the score.
LimoneneNeutral record
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · antioxidant
No source citation attached.
Read Limonene report →gamma-TerpineneAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
animal · effect
No source citation attached.
Read gamma-Terpinene report →1,8-cineoleAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read 1,8-cineole report →alpha-TerpineolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read alpha-Terpineol report →p-CymeneAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
animal · effect
No source citation attached.
Read p-Cymene report →EugenolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Eugenol report →FarnesolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Farnesol report →beta-PineneAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read beta-Pinene report →1,8-cineoleAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · antioxidant
No source citation attached.
Read 1,8-cineole report →CampheneNeutral record
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
traditional · effect
No source citation attached.
Read Camphene report →LimoneneAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
animal · effect
No source citation attached.
Read Limonene report →How the effects were investigated
mapk and nf kb suppression
The strongest mechanism signal in the located literature is anti-inflammatory pathway modulation through suppression of MAPKs and the NF-kB pathway.
This experimental finding does not establish benefit, dose or safety in people using this blend.
No direct public citation is attached to this entry.
central nervous system exposure after inhalation
Inhalation studies indicate alpha-pinene reaches the brain and other tissues, offering a mechanistic basis for observed behavioral effects in animal models.
This experimental finding does not establish benefit, dose or safety in people using this blend.
No direct public citation is attached to this entry.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (6)
- Although alpha-pinene has more literature than many constituents, much of it is still preclinical and model-specific.
- The identified clinical literature is narrow and should not be generalized into broad digestive, anti-inflammatory, or anxiolytic claims.
- Constituent-specific finished-product exposure guidance remains less clear than the basic hazard and toxicokinetic literature.
- No constituent-specific numeric dermal reference is available here.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.
- Interaction candidates lack an attached source citation and remain unqualified.